Non-Small Cell Lung Cancer in the Elderly: Defining Treatment Options
To access this article, please choose from the options below
Supported in part by Grant No. K12 CA 01727 from the National Cancer Institute and by the Phase One Foundation (K.L.R.). K.L. Reckamp has received honoraria from Genentech and Eli Lilly.
PII: S0093-7754(08)00192-9
doi:10.1053/j.seminoncol.2008.08.009
© 2008 Elsevier Inc. All rights reserved.
